
'Mad Money' Lightning Round: Northrop Grumman, Lockheed Martin Both Terrific
Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.
Here's what Jim Cramer had to say about some of the stocks during the Mad Money Lightning Round Tuesday evening:
Stryker (SYK) - Get Report : "This is very interesting right here, but I prefer Edwards Lifesciences (EW) - Get Report ."
Johnson & Johnson (JNJ) - Get Report : "This one is good and going higher. "
Merck (MRK) - Get Report : "I think Merck lags Johnson & Johnson (JNJ) - Get Report , I'd stick with Johnson."
Unilever plc (UL) - Get Report : "I like Unilever. Things are going very well."
Goldman Sachs (GS) - Get Report : "I love it."
China Mobile (CHL) - Get Report : "No, I'm not recommending any Chinese stocks."
Dyax Corp (DYAX) : "That one is too speculative for me."
GW Pharmaceuticals (GWPH) - Get Report : "That one is also too speculative. "
Abiomed (ABMD) - Get Report : "I think that represents great value."
Northrop Grumman (NOC) - Get Report : "That one is absolutely terrific. I like Lockheed Martin (LMT) - Get Report a little more but both are terrific."
Baidu.com (BIDU) - Get Report : "I do not trust Baidu."
To read a full recap of "Mad Money" on CNBC, click here.
To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.
To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.
At the time of publication, Cramer's Action Alerts PLUS had a position in LMT.








